In vitro evaluation of josamycin, spiramycin, and erythromycin against Rickettsia rickettsii and R. conorii
- PMID: 3129987
- PMCID: PMC172145
- DOI: 10.1128/AAC.32.2.255
In vitro evaluation of josamycin, spiramycin, and erythromycin against Rickettsia rickettsii and R. conorii
Abstract
The antimicrobial activities of josamycin, erythromycin, and spiramycin against Rickettsia conorii and R. rickettsii were evaluated in two tests: a dye-uptake assay and a plaque assay. The MIC of josamycin was 1 microgram/ml for both species; the MICs of erythromycin and spiramycin were 4 to 8 and 16 to 32 micrograms/ml, respectively, for both species. Only josamycin may be of clinical use in treating spotted fever rickettsiosis. It may be useful in treating pregnant women and young children.
Similar articles
-
In vitro susceptibilities of Rickettsia rickettsii and Rickettsia conorii to roxithromycin and pristinamycin.Antimicrob Agents Chemother. 1989 Dec;33(12):2146-8. doi: 10.1128/AAC.33.12.2146. Antimicrob Agents Chemother. 1989. PMID: 2515795 Free PMC article.
-
In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycin.Antimicrob Agents Chemother. 1993 Dec;37(12):2633-7. doi: 10.1128/AAC.37.12.2633. Antimicrob Agents Chemother. 1993. PMID: 8109928 Free PMC article.
-
Susceptibility of Rickettsia conorii and R. rickettsii to pefloxacin, in vitro and in ovo.J Antimicrob Chemother. 1987 Mar;19(3):303-5. doi: 10.1093/jac/19.3.303. J Antimicrob Chemother. 1987. PMID: 3106303
-
Susceptibility of Rickettsia conorii, R. rickettsii, and Coxiella burnetii to PD 127,391, PD 131,628, pefloxacin, ofloxacin, and ciprofloxacin.Antimicrob Agents Chemother. 1992 Nov;36(11):2529-32. doi: 10.1128/AAC.36.11.2529. Antimicrob Agents Chemother. 1992. PMID: 1336950 Free PMC article.
-
Macrolides and gastrointestinal motility.J Antimicrob Chemother. 1988 Jul;22 Suppl B:201-6. doi: 10.1093/jac/22.supplement_b.201. J Antimicrob Chemother. 1988. PMID: 3053572 Review.
Cited by
-
Antibiotic susceptibility of rickettsia and treatment of rickettsioses.Eur J Epidemiol. 1989 Dec;5(4):432-5. doi: 10.1007/BF00140135. Eur J Epidemiol. 1989. PMID: 2606171
-
In vitro susceptibilities of Rickettsia rickettsii and Rickettsia conorii to roxithromycin and pristinamycin.Antimicrob Agents Chemother. 1989 Dec;33(12):2146-8. doi: 10.1128/AAC.33.12.2146. Antimicrob Agents Chemother. 1989. PMID: 2515795 Free PMC article.
-
In vitro susceptibilities of 27 rickettsiae to 13 antimicrobials.Antimicrob Agents Chemother. 1998 Jul;42(7):1537-41. doi: 10.1128/AAC.42.7.1537. Antimicrob Agents Chemother. 1998. PMID: 9660979 Free PMC article.
-
Antimicrobial therapy of rickettsial diseases.Antimicrob Agents Chemother. 1991 Dec;35(12):2457-62. doi: 10.1128/AAC.35.12.2457. Antimicrob Agents Chemother. 1991. PMID: 1810178 Free PMC article. Review. No abstract available.
-
Randomized Trial of Clarithromycin for Mediterranean Spotted Fever.Antimicrob Agents Chemother. 2015 Dec 28;60(3):1642-5. doi: 10.1128/AAC.01814-15. Antimicrob Agents Chemother. 2015. PMID: 26711765 Free PMC article. Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources